Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Clinical trial NCT05947383 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05947383
- Sponsor
- Sunstone Medical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2027-04-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.